tiprankstipranks
Jazz Pharmaceuticals (JAZZ)
:JAZZ
US Market

Jazz Pharmaceuticals (JAZZ) Income Statement

Compare
1,586 Followers

Jazz Pharmaceuticals Income Statement

Last quarter (Q4 2024), Jazz Pharmaceuticals's total revenue was $1.09B, an increase of 7.53% from the same quarter last year. In Q4, Jazz Pharmaceuticals's net income was $191.12M. See Jazz Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 4.07B$ 3.83B$ 3.66B$ 3.09B$ 2.36B
Gross Profit
$ 4.07B$ 3.40B$ 3.12B$ 2.65B$ 2.21B
Operating Expenses
$ 3.35B$ 2.82B$ 2.61B$ 2.48B$ 1.45B
Depreciation and Amortization
$ 0.00$ 638.70M$ 629.47M$ 552.48M$ 278.25M
EBITDA
$ 716.63M$ 1.23B$ 553.78M$ 1.03B$ 649.65M
Operating Income
$ 716.63M$ 578.58M$ 512.27M$ 170.28M$ 765.46M
Other Income/Expenses
$ -246.28M$ -280.65M$ -307.26M$ -283.12M$ -102.98M
Pretax Income
$ 470.35M$ 297.93M$ -372.78M$ -112.84M$ 275.10M
Net Income
$ 560.12M$ 414.83M$ -214.14M$ -328.95M$ 238.62M
Per Share Metrics
Basic EPS
$ 9.06$ 6.95$ -3.42$ -5.51$ 4.28
Diluted EPS
$ 8.49$ 6.10$ -3.42$ -5.51$ 4.22
Weighted Average Shares Outstanding
61.84M 63.29M 62.54M 59.69M 55.71M
Weighted Average Shares Outstanding (Diluted)
66.01M 72.07M 62.54M 59.69M 56.52M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis